Poziom B Dane pochodzące z jednej randomizowanej próby klinicznej lub dużych badań
nierandomizowanych Poziom C Uzgodniona opinia ekspertów i/lub dane pochodzące z …

Background: Abdominal aortic aneurysm (AAA), a progressive segmental abdominal aortic
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …

Introduction Abdominal aortic aneurysm (AAA) is a condition that has considerable
socioeconomic impact and an eventual rupture is associated with high mortality and …

Objective To investigate whether the relative size of intraluminal thrombus (ILT) in
abdominal aortic aneurysms (AAAs) is associated with AAA growth. Methods This large …

Aims To evaluate if ticagrelor, an effective platelet inhibitor without known non-responders,
could inhibit growth of small abdominal aortic aneurysms (AAAs). Methods and results In this …

Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health
issue with an unmet medical need for therapy. This disease is featured by a progressive …

Objective—Abdominal aortic aneurysm (AAA) is a permanent dilation of the abdominal aorta
associated with rupture, which frequently results in fatal consequences. AAA tissue is …

Aims Abdominal aortic aneurysm (AAA) is a highly lethal disease with progressive dilatation
of the abdominal aorta accompanied by degradation and remodelling of the vessel wall due …

Background: Inflammation is a key element behind the pathophysiology of cerebral
aneurysm formation and rupture. Aspirin is a potent inhibitor of cyclooxygenase-2 (COX) …

Abdominal aortic aneurysm (AAA) is a progressive aortic dilatation, causing∼ 80% mortality
upon rupture. Currently, there is no approved drug therapy for AAA. Surgical repairs are …